Suppr超能文献

RNA作为一种小分子可成药靶点。

RNA as a small molecule druggable target.

作者信息

Rizvi Noreen F, Smith Graham F

机构信息

Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.

AstraZeneca, Darwin Building, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, UK.

出版信息

Bioorg Med Chem Lett. 2017 Dec 1;27(23):5083-5088. doi: 10.1016/j.bmcl.2017.10.052. Epub 2017 Oct 23.

Abstract

Small molecule drugs have readily been developed against many proteins in the human proteome, but RNA has remained an elusive target for drug discovery. Increasingly, we see that RNA, and to a lesser extent DNA elements, show a persistent tertiary structure responsible for many diverse and complex cellular functions. In this digest, we have summarized recent advances in screening approaches for RNA targets and outlined the discovery of novel, drug-like small molecules against RNA targets from various classes and therapeutic areas. The link of structure, function, and small-molecule Druggability validates now for the first time that RNA can be the targets of therapeutic agents.

摘要

小分子药物已很容易针对人类蛋白质组中的许多蛋白质开发出来,但RNA仍然是药物发现中难以捉摸的靶点。我们越来越多地看到,RNA以及程度稍轻的DNA元件呈现出一种持久的三级结构,这种结构负责许多多样而复杂的细胞功能。在本综述中,我们总结了RNA靶点筛选方法的最新进展,并概述了针对来自各类别和治疗领域的RNA靶点发现新型、类药物小分子的情况。结构、功能与小分子可成药性之间的联系首次证实RNA可以成为治疗药物的靶点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验